אוולטרה ®
Country: Iżrael
Lingwa: Ebrajk
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
CLOFARABINE 1 MG/ML
Disponibbli minn:
SANOFI - AVENTIS ISRAEL LTD
Kodiċi ATC:
L01BB06
Għamla farmaċewtika:
CONCENTRATE FOR SOLUTION FOR INFUSION
Rotta amministrattiva:
I.V
Manifatturat minn:
GENZYME EUROPE B.V., NETHERLANDS
Grupp terapewtiku:
CLOFARABINE
Indikazzjonijiet terapewtiċi:
Treatment of acute lymphoblastic leukaemia (ALL) in paediatric patients who have relapsed or are refractory after receiving at least two prior regimens and who are about to undergo transplantation. Safety and efficacy have been assessed in studies of patients < or = 21 years old at initial diagnosis .
Data ta 'l-awtorizzazzjoni:
2012-04-01
